Impact of CYP2D6 polymorphism on plasma levels of donepezil: clinical relevance in patients with Alzheimer’s disease
M.G. Scordo, Giuseppe Lombardi(University of Pisa), Gianluca Miglio(University of Turin), Federica Varsaldi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Aldo Biolcati(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), M-L. Dahl, Laura Villa(IRCCS Eugenio Medea)
Unknown
January 1, 2004
Cited by 0
Related Papers
Endoscopic Endonasal Transsphenoidal Approach: Outcome Analysis of 100 Consecutive Procedures
|min - Minimally Invasive Neurosurgery|2002|348
Prevalence and correlates of mental disorders among adolescents in Italy: the PrISMA study
|European Child & Adolescent Psychiatry|2009|156
Prone Position in Acute Respiratory Distress Syndrome Patients
|Dimensions of Critical Care Nursing|2019|112
The behavioural phenotype of Cornelia de Lange Syndrome: a study of 56 individuals
|Journal of Intellectual Disability Research|2007|100
Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patients
|European Journal of Clinical Pharmacology|2006|96